DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the HEALTH X PLATFORM LIMITED (HEALTHX) share price today?

HEALTH X PLATFORM LIMITED (HEALTHX) is trading at ₹317.6 on the NSE, down 2.01% on the day. Source: DocStoX.

What is the PE ratio of HEALTH X PLATFORM LIMITED?

HEALTH X PLATFORM LIMITED has a price-to-earnings (PE) ratio of 858.4 in the Healthcare sector.

What is the market capitalisation of HEALTH X PLATFORM LIMITED?

HEALTH X PLATFORM LIMITED has a market capitalisation of approximately ₹1,025 crore.

HEALTH X PLATFORM LIMITED

HEALTHX·NSE·Healthcare

₹317.60▼ -6.50 (-2.01%)

Healthcare · Healthcare Services

A steady, established business

Day₹313.95

₹332.00

52W₹269

₹34862%

Open

₹328.00

High

₹332.00

Low

₹313.95

Prev Close

₹324.10

Volume

3.8K

VWAP

₹322.48

Snapshot

Key fundamentals

Market Cap

₹1,025 Cr

P/E Ratio

858.38Expensive

P/B Ratio

1.57

EPS

₹0.37

Book Value

₹201.00

ROE

0.29%Weak

ROCE

-4.88%Weak

Dividend Yield

N/A

Debt / Equity

N/A

Face Value

₹10.00

52W High

₹347.85

52W Low

₹269.00

Sector

Healthcare

Industry

Healthcare Services

Avoid

None moatHigh uncertainty

Fair value estimate

₹142

▼ 55.3%downside

Trading at ₹318 — 55% above our estimate

BearFair valueBull

₹41₹142₹170

/100

Business quality — Watch the fundamentals

Growth 30Profitability 0Efficiency 0Valuation 0

Plain English

Our view

A steady, established business
Promoters hold a controlling stake
Weak returns on equity (0%)

Strengths

Promoters hold a controlling stake

Risks

Weak returns on equity (0%)
Expensive — trades at 858× earnings
Fundamental red flags (Piotroski 3/9)

How we got there

Fair value methods

Residual income

0% ROE fading to 13% over ~3 yrs, on ₹201 book

₹170

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹41

Analyst target

No analyst coverage

—

Blended fair value₹142

What the numbers say

Investment thesis

Bull case

Promoters hold a controlling stake

Bear case

Weak returns on equity (0%)
Expensive — trades at 858× earnings
Fundamental red flags (Piotroski 3/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

858.4Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

0.3%Weak

Above 15% is considered healthy for Indian equities

ROCE

-4.9%Weak

Above 18% means capital is working hard

Debt/Eq

—

Mkt Cap

₹1,025 Cr

P/B

1.57

EPS

₹0.37

Div Yield

—

What changed

Recent changes

Domestic institutions+0.5% stake last quarter
Promoters+0.15% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 858.4×

Growth

Steady

+8% rev CAGR

Profitability

Modest

0.3% ROE

Financial health

N/A

No debt data

Momentum

N/A

No technicals

Today

Trading activity

Delivery %56.5%

Turnover₹12.35L Cr

Trades307

VWAP₹322.48

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+7.6%

+19.1%

10Y

+30.9%

Profit

—

10Y

—

EPS

—

10Y

—

Profile

Pros

Company is almost debt free.
Company's median sales growth is 36.1% of last 10 years
Company's working capital requirements have reduced from 40.4 days to 16.0 days

Watch-outs

Cons

Company has low interest coverage ratio.
Company has a low return on equity of 2.06% over last 3 years.
Earnings include an other income of Rs.57.1 Cr.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.15 pts; domestic institutions added 0.53 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

75%

Promoter

Promoters

74.8%+0.15

Public

20.4%-0.61

FII / FPI

2.2%-0.08

DII

2.6%+0.53

Total shareholders

11,845

Quarterly trend

Ownership over time

Q4 FY26

Promoter74.84%

FII2.17%

DII2.60%

Public20.38%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]